Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
600664.SS Stock Summary
Top 10 Correlated ETFs
600664.SS
In the News
600664.SS Financial details
Company Rating
Buy
Market Cap
7.59B
Income
598.45M
Revenue
15.31B
Book val./share
2.26
Cash/share
1.32
Dividend
-
Dividend %
-
Employees
10.06K
Optionable
No
Shortable
Yes
Earnings
11 Apr 2024
P/E
14
Forward P/E
11.27
PEG
2.22
P/S
0.54
P/B
1.81
P/C
2.22
P/FCF
8.37
Quick Ratio
1.01
Current Ratio
1.25
Debt / Equity
0.44
LT Debt / Equity
0.01
-
-
EPS (TTM)
0.24
EPS next Y
0.26
EPS next Q
-
EPS this Y
26.67%
EPS next Y
6.3%
EPS next 5Y
6.3%
EPS last 5Y
6.3%
Revenue last 5Y
5.01%
Revenue Q/Q
0.49%
EPS Q/Q
96.33%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
4%
ROE
13%
ROC
0.15%
Gross Margin
26%
Oper. Margin
6%
Profit Margin
4%
Payout
8%
Shs Outstand
2.52B
Shs Float
1.2B
-
-
-
-
Target Price
-
52W Range
2.41-3.9
52W High
-2.33%
52W Low
+46.5%
RSI
47
Rel Volume
0.72
Avg Volume
33.74M
Volume
24.39M
Perf Week
-3.62%
Perf Month
11.83%
Perf Quarter
-
Perf Half Y
-13.82%
-
-
-
-
Beta
0.157
-
-
Volatility
0.06%, 0.07%
Prev Close
0.69%
Price
2.93
Change
0%
600664.SS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 4.37 | 4.24 | 4.3 | 5.17 | 5.49 | |
Net income per share | 0.14 | 0.04 | -0.42 | 0.15 | 0.18 | |
Operating cash flow per share | 0.28 | -0.1 | -0.29 | -0.07 | 0.25 | |
Free cash flow per share | 0.23 | -0.12 | -0.34 | -0.1 | 0.21 | |
Cash per share | 0.79 | 0.21 | 0.33 | 0.62 | 0.95 | |
Book value per share | 2.37 | 1.96 | 1.39 | 1.56 | 1.72 | |
Tangible book value per share | 2.32 | 1.94 | 1.38 | 1.56 | 1.76 | |
Share holders equity per share | 2.37 | 1.96 | 1.39 | 1.56 | 1.72 | |
Interest debt per share | 0.11 | 0.26 | 0.73 | 0.98 | 0.89 | |
Market cap | 9.17B | 10.58B | 8B | 8.78B | 7.58B | |
Enterprise value | 7.38B | 10.57B | 8.87B | 9.5B | 7.3B | |
P/E ratio | 26.5 | 86.79 | -7.65 | 23.67 | 16.31 | |
Price to sales ratio | 0.85 | 0.89 | 0.74 | 0.69 | 0.55 | |
POCF ratio | 13.24 | -37.12 | -10.98 | -54.07 | 12.18 | |
PFCF ratio | 15.85 | -32.65 | -9.45 | -36.73 | 14.23 | |
P/B Ratio | 1.56 | 1.94 | 2.3 | 2.28 | 1.75 | |
PTB ratio | 1.56 | 1.94 | 2.3 | 2.28 | 1.75 | |
EV to sales | 0.68 | 0.89 | 0.82 | 0.74 | 0.53 | |
Enterprise value over EBITDA | 6.15 | 10.57 | -301.64 | 10.58 | 7.06 | |
EV to operating cash flow | 10.65 | -37.11 | -12.18 | -58.5 | 11.73 | |
EV to free cash flow | 12.75 | -32.64 | -10.48 | -39.74 | 13.71 | |
Earnings yield | 0.04 | 0.01 | -0.13 | 0.04 | 0.06 | |
Free cash flow yield | 0.06 | -0.03 | -0.11 | -0.03 | 0.07 | |
Debt to equity | 0.04 | 0.12 | 0.51 | 0.6 | 0.5 | |
Debt to assets | 0.02 | 0.05 | 0.15 | 0.18 | 0.16 | |
Net debt to EBITDA | -1.5 | 0 | -29.81 | 0.8 | -0.27 | |
Current ratio | 1.41 | 1.2 | 1.07 | 1.11 | 1.19 | |
Interest coverage | 22.71 | 13.62 | -9.91 | 6.11 | 8.13 | |
Income quality | 1.72 | -2.34 | 0.7 | -0.4 | 1.22 | |
Dividend Yield | 0.15 | 0 | 0 | 0.01 | 0.01 | |
Payout ratio | 3.9 | 0.08 | -0.01 | 0.17 | 0.12 | |
Sales general and administrative to revenue | 0.03 | 0.03 | 0.02 | 0.01 | 0.01 | |
Research and developement to revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Intangibles to total assets | 0.05 | 0.04 | 0.04 | 0.04 | 0.04 | |
Capex to operating cash flow | -0.16 | 0.14 | 0.16 | 0.47 | -0.14 | |
Capex to revenue | -0.01 | 0 | -0.01 | -0.01 | -0.01 | |
Capex to depreciation | -0.27 | -0.1 | -0.32 | -0.25 | -0.29 | |
Stock based compensation to revenue | 0 | 0 | 0.02 | 0 | 0 | |
Graham number | 2.73 | 1.39 | 3.61 | 2.29 | 2.67 | |
ROIC | 0.06 | 0.04 | -0.12 | 0.07 | 0.08 | |
Return on tangible assets | 0.03 | 0.01 | -0.09 | 0.03 | 0.04 | |
Graham Net | -0.1 | -0.55 | -0.95 | -0.85 | -0.5 | |
Working capital | 2.11B | 1.24B | 501.08M | 878.23M | 1.56B | |
Tangible asset value | 5.73B | 5.42B | 3.46B | 3.85B | 4.42B | |
Net current asset value | 1.58B | 747.36M | -51.09M | 311.05M | 1.07B | |
Invested capital | 0.04 | 0.12 | 0.51 | 0.6 | 0.5 | |
Average receivables | 3.61B | 4B | 4.76B | 4.98B | 5.13B | |
Average payables | 3.25B | 3.43B | 3.7B | 3.58B | 3.5B | |
Average inventory | 1.71B | 1.86B | 1.94B | 1.96B | 1.93B | |
Days sales outstanding | 115.95 | 140.72 | 167.98 | 142.6 | 138.97 | |
Days payables outstanding | 145.3 | 151.07 | 158.6 | 130.15 | 123.15 | |
Days of inventory on hand | 78.17 | 82.22 | 80.5 | 77.13 | 63.3 | |
Receivables turnover | 3.15 | 2.59 | 2.17 | 2.56 | 2.63 | |
Payables turnover | 2.51 | 2.42 | 2.3 | 2.8 | 2.96 | |
Inventory turnover | 4.67 | 4.44 | 4.53 | 4.73 | 5.77 | |
ROE | 0.06 | 0.02 | -0.3 | 0.1 | 0.11 | |
Capex per share | -0.05 | -0.01 | -0.05 | -0.03 | -0.04 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q3
Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 1.42 | 1.52 | 1.61 | 1.54 | 1.86 | |
Net income per share | 0.02 | 0.12 | 0.05 | 0.02 | 0.05 | |
Operating cash flow per share | 0.02 | 0.12 | 0.05 | 0.14 | 0.13 | |
Free cash flow per share | 0.02 | 0.11 | 0.04 | 0.14 | 0.13 | |
Cash per share | 0.71 | 0.95 | 0.97 | 1.03 | 1.32 | |
Book value per share | 1.6 | 1.72 | 1.82 | 1.85 | 2.26 | |
Tangible book value per share | 1.62 | 1.76 | 1.87 | 1.9 | 2.33 | |
Share holders equity per share | 1.6 | 1.72 | 1.82 | 1.85 | 2.26 | |
Interest debt per share | 0.88 | 0.87 | 0.86 | 0.82 | 0.99 | |
Market cap | 6.63B | 7.58B | 7.61B | 8.05B | 7.09B | |
Enterprise value | 7.02B | 7.3B | 7.26B | 7.45B | 6.34B | |
P/E ratio | 32.37 | 6.15 | 15.55 | 33.3 | 16.44 | |
Price to sales ratio | 1.85 | 1.98 | 1.93 | 2.13 | 1.87 | |
POCF ratio | 129.46 | 24.6 | 62.2 | 23.07 | 25.86 | |
PFCF ratio | 170.84 | 26.8 | 71.7 | 23.7 | 27.33 | |
P/B Ratio | 1.65 | 1.75 | 1.71 | 1.78 | 1.53 | |
PTB ratio | 1.65 | 1.75 | 1.71 | 1.78 | 1.53 | |
EV to sales | 1.96 | 1.91 | 1.85 | 1.98 | 1.67 | |
Enterprise value over EBITDA | 51.7 | 26.44 | 34.36 | 50.24 | 33.42 | |
EV to operating cash flow | 137.16 | 23.7 | 59.38 | 21.37 | 23.12 | |
EV to free cash flow | 181 | 25.82 | 68.44 | 21.96 | 24.44 | |
Earnings yield | 0.01 | 0.04 | 0.02 | 0.01 | 0.02 | |
Free cash flow yield | 0.01 | 0.04 | 0.01 | 0.04 | 0.04 | |
Debt to equity | 0.55 | 0.5 | 0.47 | 0.44 | 0.44 | |
Debt to assets | 0.17 | 0.16 | 0.15 | 0.15 | 0.14 | |
Net debt to EBITDA | 2.9 | -1 | -1.63 | -3.99 | -3.96 | |
Current ratio | 1.16 | 1.19 | 1.22 | 1.23 | 1.25 | |
Interest coverage | 9.72 | 15.89 | 11.96 | 9.58 | 12.27 | |
Income quality | 1 | 1 | 1 | 5.77 | 2.54 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0.28 | 0.05 | 0.1 | 0.17 | 0.09 | |
Sales general and administrative to revenue | 0.14 | -0.11 | 0.05 | -0.03 | 0.14 | |
Research and developement to revenue | 0.01 | 0.01 | 0.01 | 0 | 0.01 | |
Intangibles to total assets | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | |
Capex to operating cash flow | -0.24 | -0.08 | -0.13 | -0.03 | -0.05 | |
Capex to revenue | 0 | -0.01 | 0 | 0 | 0 | |
Capex to depreciation | -0.17 | -0.35 | -0.21 | -0.12 | 0.1 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 0.86 | 2.18 | 1.43 | 1.01 | 1.64 | |
ROIC | 0.01 | 0.05 | 0.02 | 0.01 | 0.02 | |
Return on tangible assets | 0 | 0.02 | 0.01 | 0 | 0.01 | |
Graham Net | -0.66 | -0.5 | -0.44 | -0.43 | -0.42 | |
Working capital | 1.22B | 1.56B | 1.75B | 1.86B | 2.03B | |
Tangible asset value | 4.08B | 4.42B | 4.57B | 4.64B | 4.77B | |
Net current asset value | 674.71M | 1.07B | 1.26B | 1.38B | 1.58B | |
Invested capital | 0.55 | 0.5 | 0.47 | 0.44 | 0.44 | |
Average receivables | 5.28B | 5.36B | 5.37B | 5.46B | 5.49B | |
Average payables | 3.61B | 3.63B | 3.6B | 3.84B | 3.9B | |
Average inventory | 1.71B | 1.77B | 1.77B | 1.79B | 1.83B | |
Days sales outstanding | 137.31 | 123.93 | 125.64 | 129.46 | 131.68 | |
Days payables outstanding | 120.67 | 117.2 | 112.79 | 125.77 | 122.84 | |
Days of inventory on hand | 55.76 | 60.24 | 53.1 | 58.33 | 58.23 | |
Receivables turnover | 0.66 | 0.73 | 0.72 | 0.7 | 0.68 | |
Payables turnover | 0.75 | 0.77 | 0.8 | 0.72 | 0.73 | |
Inventory turnover | 1.61 | 1.49 | 1.69 | 1.54 | 1.55 | |
ROE | 0.01 | 0.07 | 0.03 | 0.01 | 0.02 | |
Capex per share | 0 | -0.01 | -0.01 | 0 | -0.01 |
600664.SS Frequently Asked Questions
What is Harbin Pharmaceutical Group Co., Ltd. stock symbol ?
Harbin Pharmaceutical Group Co., Ltd. is a CN stock and trading under the symbol 600664.SS
What is Harbin Pharmaceutical Group Co., Ltd. stock quote today ?
Harbin Pharmaceutical Group Co., Ltd. stock price is $2.93 today.
Is Harbin Pharmaceutical Group Co., Ltd. stock public?
Yes, Harbin Pharmaceutical Group Co., Ltd. is a publicly traded company.